Search results

Selected filters:

Technology Licensing

Article type

Topic

Sector

Regions

3,420 results found for your search

Sort options
20 November 2019

South Korean NPE returns in deal with Samsung

Smartphone giant's LTE play makes it the latest operating company to pony up for former Pantech patents

19 November 2019

Second listing sees Alibaba on firmer IP footing

The e-commerce giant prices its Hong Kong offering this week. Five years after its NYSE debut, it has a more formidable patent portfolio and new IP-based alliances

16 November 2019

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show

A judgment that upholds the Unwired Planet and Conversant decisions could well leave British Prime Minister Boris Johnson in a difficult position

15 November 2019

Another big LG assertion could signal a strategy shift

The Korean electronics giant has accused TCL of infringement in Germany, in another lawsuit targeting a Chinese rival

14 November 2019

Legal landscape more rational now but will shift back, says Facebook IP supremo

Get your deals done now before the market begins to rebalance in favour of patent owners, Allen Lo advises licensees while speaking on panel at the annual IP Dealmakers conference

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

12 November 2019

Korean NPE launches offensive after streaming pool's collapse

State research lab ETRI and patent fund Intellectual Discovery are two of the entities in line to profit from the assertion effort

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

12 November 2019

After declaring itself litigation free, Immersion makes substantial cuts to its patent portfolio and puts more emphasis on technology licensing

In a play that is becoming familiar in the IP market, CEO Ramzi Haidamus is overseeing a major scaling back of the haptics leader's assets while looking to move beyond pure monetisation

11 November 2019

It is time for the German courts to be courageous on FRAND

The Dusseldorf Court of Appeal’s decision in Unwired Planet v Huawei is one that had licensees cheering and licensors in despair - but it may not last long 

09 November 2019

The patent dodgers trolling the IP landscape

IPCom is one of Europe’s oldest NPEs – and usually one of its most reticent. Not anymore, though. In this opinion piece, managing director Pio Suh explains why he believes firms such as his have a key role to play in FRAND licensing

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

08 November 2019

Blackberry portfolio licensor inks RPX agreement and insists there’s still plenty more deals to do

Defensive aggregator closes transaction with Fundamental Innovation Systems International giving members coverage on USB charging patents; Apple also settles infringement case

07 November 2019

New suit suggests LG China licensing push

Korean company is the latest infrequent plaintiff to sue a Chinese TV maker, underlining challenges for licensors in the space

07 November 2019

Multi-billion dollar IP dispute exposes dangers of life sciences collaborations

Seattle Genetics is demanding rights to Daiichi Sankyo’s potential blockbuster cancer treatment, which it says is an improvement on the proprietary technology included in their previous partnership